Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2005
12/29/2005WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer
12/29/2005WO2002099040A3 Igs as modifiers of the p53 pathway and methods of use
12/29/2005WO2002033113A3 Protein-protein interactions in neurodegenerative diseases
12/29/2005US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
12/29/2005US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition
12/29/2005US20050289657 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
12/29/2005US20050288498 Novel human ion channel-related proteins and polynucleotides encoding the same
12/29/2005US20050288486 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
12/29/2005US20050288368 Compositions and methods for treating and preventing necrosis
12/29/2005US20050288359 Agents and methods for the treatment of disorders associated with oxidative stress
12/29/2005US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
12/29/2005US20050288260 Novel nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
12/29/2005US20050288255 Modulation of lysophosphatidylcholine and treatment of diet-induced conditions
12/29/2005US20050288253 Boronic acid salts
12/29/2005US20050288248 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction
12/29/2005US20050288234 administering (R)-2-acetamido-N-benzyl-3-methoxypropionamide; tremor comprises rhythmic oscillatory movement
12/29/2005US20050288233 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS
12/29/2005US20050288232 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester
12/29/2005US20050288231 Biologically active peptides as glutamate receptor inhibitors
12/29/2005US20050288229 Bone and/or cartilage development-stimulating peptide incorporating proline or hydroxyproline; implants
12/29/2005US20050288228 Bile-acid conjugates for providing sustained systemic concentrations of drugs
12/29/2005US20050288227 Use of thioredoxin measurements for diagnostics and treatments
12/29/2005US20050288226 Administering to a cancer cell exhibiting reduced WIF-1 expression an effective amount of a polypeptide operably linked to a signal sequence or fused to a heterologous amino acid sequence, wherein said administering inhibits cancer cell proliferation
12/29/2005US20050288225 Modulators of intracellular inflammation, cell death and cell survival pathways
12/29/2005US20050288223 OBG3 Fragments Inhibiting The Conversion Of Active OBG3 Into Less Active OBG3 And Other Compositions For Treatment Of Metabolic Disorders
12/29/2005US20050288222 Methods for enhancing the bioavailability of a drug
12/29/2005US20050288220 Erythropoietin with high specific activity
12/29/2005US20050288219 Osteoprotegerin in milk
12/29/2005US20050288218 Methods for treating and preventing sepsis using modified C1 inhibitor or fragments thereof
12/29/2005US20050288217 Method for enhancing or inhibiting insulin-like growth factor-I
12/29/2005US20050288215 Inhibition of nuclear export as a treatment for cardiac hypertrophy and heart failure
12/29/2005US20050288214 Nucleotide sequence encoding PTD and CEA fusion protein, Tat-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein
12/29/2005US20050288213 Combination therapy for the treatment of obesity
12/29/2005US20050288212 Components of the presenilin-complex
12/29/2005US20050288211 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis
12/29/2005US20050287671 Soluble steroidal peptides for nucleic acid delivery
12/29/2005US20050287665 Using stem cell culture comprising dibutyryl cAMP and pituitary adenylate cyclase-activating polypeptide (PACAP) as therapeujtic treating spinal cord injuries
12/29/2005US20050287648 Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof
12/29/2005US20050287647 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
12/29/2005US20050287643 Protein binding miniature proteins and uses thereof
12/29/2005US20050287642 Efficient protein expression system
12/29/2005US20050287640 Human spasmolytic polypeptide in glycosylated form
12/29/2005US20050287638 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents
12/29/2005US20050287636 Polypeptide; low density lipoprotein antioxidant, efficient delivery of cholesterol to hepatocytes
12/29/2005US20050287635 RTD receptor
12/29/2005US20050287631 Compositions and methods related to a dimeric MHC class I and II-Like molecule (dsMHCI and dsMHCII)
12/29/2005US20050287628 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
12/29/2005US20050287627 In presence of ATP and peptidases
12/29/2005US20050287626 Process for producing dipeptides
12/29/2005US20050287610 Method for detecting the presence or risk of prostate cancer by detecting products of psa or klk2
12/29/2005US20050287606 T1 receptor-like ligand I
12/29/2005US20050287605 Caspase 3 inhibitors
12/29/2005US20050287603 Modulation of bone development
12/29/2005US20050287601 Diagnostics and therapeutics for macular degeneration-related disorders
12/29/2005US20050287584 Secreted proteins encoded by human chromosome 13
12/29/2005US20050287579 Genes for male accessory gland proteins in Drosophila melanogaster
12/29/2005US20050287568 Novel human transferase proteins and polynucleotides encoding the same
12/29/2005US20050287564 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/29/2005US20050287554 Regions of papilloma virus E1 helicase involved in E1 oligomerization
12/29/2005US20050287546 Novel proteases
12/29/2005US20050287545 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
12/29/2005US20050287542 Avian pancreatic polypeptide comprising antigenic specificity for use in treatment and prevention of allergies, infection, inflammation, autoimmune and tumor disorders
12/29/2005US20050287532 Methods for monitoring drug activities in vivo
12/29/2005US20050287530 TCL-1b gene and protein and related methods and compositions
12/29/2005US20050287525 bioassay for testing peptides that bind to domain peptides of human immunodeficiency virus type I (HIV-1); peptides used for treating viral diseases
12/29/2005US20050287521 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof
12/29/2005US20050287247 Infant formula
12/29/2005US20050287226 High potency clinical anti-craving treatment and method of use
12/29/2005US20050287206 Solubilized CoQ-10 and carnitine
12/29/2005US20050287204 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms
12/29/2005US20050287197 Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x
12/29/2005US20050287189 Antitumor, anticancer agents; particles or coils or stents coated solid-phase agent comprising a binding agent comprising collagen are directed to target vasculature, such as the vasculature of solid tumor masses or aneurysms
12/29/2005US20050287186 Self-assembling peptides for regeneration and repair of neural tissue
12/29/2005US20050287180 Phospholipid compositions and methods for their preparation and use
12/29/2005US20050287175 modulating fusion between a lysosome and an endosome that carries the toxin in the cell; locally co-administering a toxin and a lysosome-endosome fusion inhibitor to a group of muscles of the patient in need thereof
12/29/2005US20050287168 Recombinant spores
12/29/2005US20050287165 Meningococcal antigens
12/29/2005US20050287160 Useful for treatment and prevention of prostate cancer, especially when associated with bone metastases; also a cytotoxic T lymphocyte that specifically recognizes complex of HLA-A24 antigen and the cancer antigen peptide
12/29/2005US20050287159 Treatment methods for eotaxin mediated inflammatory conditons
12/29/2005US20050287158 The p65 subunit of nf-kb for the radiosensitization of cells
12/29/2005US20050287152 Administering CTLA-4, tumor necrosis factor inhibitors, and immunogens
12/29/2005US20050287151 Secreted protein therapeutics and uses thereof
12/29/2005US20050287145 Compositions and methods for producing vascular occlusion
12/29/2005US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis
12/29/2005US20050287143 antibodies against such VEGFs, which may be used to inhibit their action, for example, to inhibit the growth of tumors, to treat diabetic retinopathy, rheumatoid arthritis and psoriasis
12/29/2005US20050287142 Remedies or preventives for rheumatoid arthritis
12/29/2005US20050287139 Wound healing
12/29/2005US20050287135 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/29/2005US20050287134 use of a first drug operative to produce local capillary vasodilatation and/or augmented rate of bulk flow which is mixed with a fluid, then delivered subcutaneously or into deeper tissues by use of a hyperdermic needle or infiltration cannula
12/29/2005US20050287133 Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
12/29/2005US20050287132 Biliverdin reductase fragments and variants, and methods of using biliverdin reductase and such fragments and variants
12/29/2005US20050287131 Health supplement
12/29/2005US20050287130 Methods of modifying cell structure and remodeling tissue
12/29/2005US20050287127 Use of stem cells to generate inner ear cells
12/29/2005US20050287123 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
12/29/2005US20050287119 Treating a superficial interferon-resistant tumor of the bladder by contacting the tumor with Syn 3 and a replication-deficient adenoviral recombinant vector encoding an interferon alpha, where the vector and Syn3 are instilled intravesically; interferon alpha 2b,2a,2 or 1
12/29/2005US20050287115 Treatment of ocular lesions
12/29/2005US20050287114 Water-soluble polymeric bone-targeting drug delivery system
12/29/2005US20050287074 Matrix metalloproteinase inhibitors
12/29/2005DE102004027924A1 Arzneiform, enthaltend den Wirkstoff Cholylsarcosin Dosage form comprising the active ingredient cholylsarcosine
1 ... 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 ... 3163